For the p53 Special Issue
p53 Review Article
TP53 mutations in workers exposed to occupational carcinogens†
Article first published online: 24 FEB 2003
DOI: 10.1002/humu.10182
© 2003 Wiley-Liss, Inc.
Issue
1098-1004/asset/cover.gif?v=1&s=b02ab57a64d28403f477b09d50f72a4d63f4c8eb)
Human Mutation
Special Issue: Focus on p53 and Cancer
Volume 21, Issue 3, pages 240–251, March 2003
Additional Information
How to Cite
Vähäkangas, K. (2003), TP53 mutations in workers exposed to occupational carcinogens. Hum. Mutat., 21: 240–251. doi: 10.1002/humu.10182
- †
Publication History
- Issue published online: 24 FEB 2003
- Article first published online: 24 FEB 2003
- Abstract
- References
- Cited By
Keywords:
- p53;
- TP53;
- tumor;
- carcinogen;
- cancer;
- risk factor;
- environment exposure;
- mutagen
Abstract
In some cases, evidence exists that exogenous carcinogenic exposures contribute to the mutation spectrum of the TP53 gene (p53) in human cancers. Although the clearest examples come from dietary and environmental sources, only a restricted number of papers have concentrated specifically on TP53 mutations in tumors from workers exposed to occupational carcinogens. In populations exposed to dietary aflatoxin B1 with liver cancer (AFB1) and ultraviolet (UV)-radiation with skin cancer, a single specific-looking TP53 mutation has been described in some of the tumors. Whether these fingerprints in the TP53 gene can be used to reveal an occupational etiology remains to be shown. In other cases, although differences in the TP53 mutation spectrum exist, they are more diffuse and difficult to interpret at this point. For instance, cigarette smoking seems to induce long-lasting molecular footprints in TP53. However, their use to rule out other occupational exposures as etiological factors in occupational cancers is still very questionable, especially due to the putative synergistic effects of cigarette smoke with other carcinogens. Although interesting implications of possible typical mutation spectra among cancers with other occupational etiologies exist, the data are scanty and await further development of TP53 mutation databases. Hum Mutat 21:240–251, 2003. © 2003 Wiley-Liss, Inc.

1098-1004/asset/HUMU_left.gif?v=1&s=4065e12063da1c0efe3c1a74d4f13c3cd92fba18)
1098-1004/asset/HUMU_right.gif?v=1&s=58026811b6aa5bee5a3d0e0563a705f8b681f34d)